What is the recommended dosage of Bactrim (trimethoprim/sulfamethoxazole) for children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Bactrim Dosage for Children

Standard Treatment Dosing

For most infections in children over 2 months of age, administer Bactrim at 8-12 mg/kg/day of the trimethoprim component and 40-60 mg/kg/day of sulfamethoxazole, divided into 2 doses given every 12 hours. 1, 2

Age-Based Restrictions

  • Do not use in infants under 2 months of age due to the risk of kernicterus 1, 2

Weight-Based Dosing Table (Every 12 Hours)

The following provides practical dosing guidance 2:

  • 10 kg (22 lbs): 1 single-strength tablet (400mg/80mg)
  • 20 kg (44 lbs): 2 single-strength tablets OR 1 double-strength tablet
  • 30 kg (66 lbs): 1½ double-strength tablets
  • 40 kg (88 lbs): 2 double-strength tablets

Indication-Specific Dosing

Urinary Tract Infections & Acute Otitis Media

  • Dose: 40 mg/kg sulfamethoxazole and 8 mg/kg trimethoprim per 24 hours, divided every 12 hours 2
  • Duration: 10 days for UTI; 10 days for otitis media 2

Shigellosis

  • Dose: Same as above (40/8 mg/kg/day divided every 12 hours) 2
  • Duration: 5 days 2, 3
  • Research demonstrates this regimen achieves clinical response within 1.7 days on average, with stool cultures clearing within 1.6 days 3

Skin and Soft Tissue Infections (including MRSA)

  • Dose: 8-12 mg/kg/day of trimethoprim component 1
  • Duration: 7-10 days 1
  • For severe MRSA osteomyelitis, the Taiwanese guidelines recommend 4 mg/kg/dose of trimethoprim every 8-12 hours, typically combined with rifampin for >6 weeks 4

Pneumocystis jirovecii Pneumonia (PCP)

Treatment:

  • Dose: 75-100 mg/kg/day sulfamethoxazole and 15-20 mg/kg/day trimethoprim, divided into 4 doses every 6 hours 2
  • Duration: 14-21 days 2

Prophylaxis:

  • Dose: 750 mg/m²/day sulfamethoxazole with 150 mg/m²/day trimethoprim, divided into 2 doses 2
  • Schedule: Given on 3 consecutive days per week (alternative to daily dosing) 5, 2
  • Maximum daily dose: Do not exceed 1600 mg sulfamethoxazole and 320 mg trimethoprim 2
  • For a 16 kg child, this equals approximately 128 mg trimethoprim per day 5

Pharmacokinetic Considerations

Age-Related Dosing Adjustments

  • Higher weight-based doses are required in younger children to achieve equivalent drug exposure compared to adults 6
  • The standard 8/40 mg/kg/day divided every 12 hours matches adult exposure and achieves therapeutic targets for bacteria with MIC ≤0.5 mg/L in >90% of children 6
  • For bacteria with MIC up to 1 mg/L, higher doses may be needed: 12/60 mg/kg/day for ages 6-21 years, or 15/75 mg/kg/day for ages 0-6 years 6

Renal Impairment

Dosing must be adjusted based on creatinine clearance 2:

  • CrCl >30 mL/min: Standard dosing
  • CrCl 15-30 mL/min: Reduce dose by 50%
  • CrCl <15 mL/min: Use not recommended 2

For IV administration in renal failure, increase the dosing interval (in hours) to 12 times the serum creatinine level in mg/dL, with a maximum interval of 48 hours 7

Monitoring Requirements

Hematologic Surveillance

  • Obtain complete blood count with differential and platelet count at treatment initiation 5
  • Repeat monthly during prolonged therapy to assess for hematologic toxicity 5
  • Thrombocytopenia risk increases with higher serum trimethoprim levels and longer treatment duration 7

Important Safety Considerations

Contraindications

  • Absolute: Age <2 months, known hypersensitivity to sulfonamides or trimethoprim 1, 2

Use with Caution

  • G6PD deficiency: Risk of hemolytic anemia 1
  • Renal insufficiency: Requires dose adjustment 1
  • Hepatic insufficiency: Monitor closely 1

Drug Interactions

  • Methotrexate: May increase toxicity 1
  • Warfarin and other anticoagulants: Enhanced anticoagulant effect 1
  • Oral hypoglycemics: Increased hypoglycemia risk 1

Common Adverse Effects

  • Rash, gastrointestinal disturbances, and hematologic abnormalities are most common 5
  • If life-threatening toxicity occurs, permanently discontinue the drug 5

Formulation Considerations

  • Liquid formulation is preferred for accurate dosing in younger children, particularly those weighing <16 kg 5
  • Intravenous administration produces more reliable peak drug levels compared to oral dosing 7

References

Guideline

Pediatric Dosage of Sulfaprim (Trimethoprim/Sulfamethoxazole)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Prophylaxis with Septran DS in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.